Cargando…

Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases

To determine whether protein tyrosine kinase (PTK) modulates volume-sensitive chloride current (I(Cl.vol)) in human atrial myocytes and to identify the PTKs involved, we studied the effects of broad-spectrum and selective PTK inhibitors and the protein tyrosine phosphatase (PTP) inhibitor orthovanad...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xin-Ling, Gao, Zhan, Lau, Chu-Pak, Chiu, Shui-Wah, Tse, Hung-Fat, Baumgarten, Clive M., Li, Gui-Rong
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217456/
https://www.ncbi.nlm.nih.gov/pubmed/15024039
http://dx.doi.org/10.1085/jgp.200409013
_version_ 1782149260043616256
author Du, Xin-Ling
Gao, Zhan
Lau, Chu-Pak
Chiu, Shui-Wah
Tse, Hung-Fat
Baumgarten, Clive M.
Li, Gui-Rong
author_facet Du, Xin-Ling
Gao, Zhan
Lau, Chu-Pak
Chiu, Shui-Wah
Tse, Hung-Fat
Baumgarten, Clive M.
Li, Gui-Rong
author_sort Du, Xin-Ling
collection PubMed
description To determine whether protein tyrosine kinase (PTK) modulates volume-sensitive chloride current (I(Cl.vol)) in human atrial myocytes and to identify the PTKs involved, we studied the effects of broad-spectrum and selective PTK inhibitors and the protein tyrosine phosphatase (PTP) inhibitor orthovanadate (VO(4) (−3)). I(Cl.vol) evoked by hyposmotic bath solution (0.6-times isosmotic, 0.6T) was enhanced by genistein, a broad-spectrum PTK inhibitor, in a concentration-dependent manner (EC(50) = 22.4 μM); 100 μM genistein stimulated I(Cl.vol) by 122.4 ± 10.6%. The genistein-stimulated current was inhibited by DIDS (4,4′-diisothiocyanostilbene-2,2′-disulfonic acid, 150 μM) and tamoxifen (20 μM), blockers of I(Cl.vol). Moreover, the current augmented by genistein was volume dependent; it was abolished by hyperosmotic shrinkage in 1.4T, and genistein did not activate Cl(−) current in 1T. In contrast to the stimulatory effects of genistein, 100 μM tyrphostin A23 (AG 18) and A25 (AG 82) inhibited I(Cl.vol) by 38.2 ± 4.9% and 40.9 ± 3.4%, respectively. The inactive analogs, daidzein and tyrphostin A63 (AG 43), did not alter I(Cl.vol). In addition, the PTP inhibitor VO(4) (−3) (1 mM) reduced I(Cl.vol) by 53.5 ± 4.5% (IC(50) = 249.6 μM). Pretreatment with VO(4) (−3) antagonized genistein-induced augmentation and A23- or A25-induced suppression of I(Cl.vol). Furthermore, the selective Src-family PTK inhibitor PP2 (5 μM) stimulated I(Cl.vol), mimicking genistein, whereas the selective EGFR (ErbB-1) kinase inhibitor tyrphostin B56 (AG 556, 25 μM) reduced I(Cl.vol), mimicking A23 and A25. The effects of both PP2 and B56 also were substantially antagonized by pretreatment with VO(4) (−3). The results suggest that I(Cl.vol) is regulated in part by the balance between PTK and PTP activity. Regulation is complex, however. Src and EGFR kinases, distinct soluble and receptor-mediated PTK families, have opposing effects on I(Cl.vol), and multiple target proteins are likely to be involved.
format Text
id pubmed-2217456
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22174562008-03-21 Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases Du, Xin-Ling Gao, Zhan Lau, Chu-Pak Chiu, Shui-Wah Tse, Hung-Fat Baumgarten, Clive M. Li, Gui-Rong J Gen Physiol Article To determine whether protein tyrosine kinase (PTK) modulates volume-sensitive chloride current (I(Cl.vol)) in human atrial myocytes and to identify the PTKs involved, we studied the effects of broad-spectrum and selective PTK inhibitors and the protein tyrosine phosphatase (PTP) inhibitor orthovanadate (VO(4) (−3)). I(Cl.vol) evoked by hyposmotic bath solution (0.6-times isosmotic, 0.6T) was enhanced by genistein, a broad-spectrum PTK inhibitor, in a concentration-dependent manner (EC(50) = 22.4 μM); 100 μM genistein stimulated I(Cl.vol) by 122.4 ± 10.6%. The genistein-stimulated current was inhibited by DIDS (4,4′-diisothiocyanostilbene-2,2′-disulfonic acid, 150 μM) and tamoxifen (20 μM), blockers of I(Cl.vol). Moreover, the current augmented by genistein was volume dependent; it was abolished by hyperosmotic shrinkage in 1.4T, and genistein did not activate Cl(−) current in 1T. In contrast to the stimulatory effects of genistein, 100 μM tyrphostin A23 (AG 18) and A25 (AG 82) inhibited I(Cl.vol) by 38.2 ± 4.9% and 40.9 ± 3.4%, respectively. The inactive analogs, daidzein and tyrphostin A63 (AG 43), did not alter I(Cl.vol). In addition, the PTP inhibitor VO(4) (−3) (1 mM) reduced I(Cl.vol) by 53.5 ± 4.5% (IC(50) = 249.6 μM). Pretreatment with VO(4) (−3) antagonized genistein-induced augmentation and A23- or A25-induced suppression of I(Cl.vol). Furthermore, the selective Src-family PTK inhibitor PP2 (5 μM) stimulated I(Cl.vol), mimicking genistein, whereas the selective EGFR (ErbB-1) kinase inhibitor tyrphostin B56 (AG 556, 25 μM) reduced I(Cl.vol), mimicking A23 and A25. The effects of both PP2 and B56 also were substantially antagonized by pretreatment with VO(4) (−3). The results suggest that I(Cl.vol) is regulated in part by the balance between PTK and PTP activity. Regulation is complex, however. Src and EGFR kinases, distinct soluble and receptor-mediated PTK families, have opposing effects on I(Cl.vol), and multiple target proteins are likely to be involved. The Rockefeller University Press 2004-04 /pmc/articles/PMC2217456/ /pubmed/15024039 http://dx.doi.org/10.1085/jgp.200409013 Text en Copyright © 2004, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Du, Xin-Ling
Gao, Zhan
Lau, Chu-Pak
Chiu, Shui-Wah
Tse, Hung-Fat
Baumgarten, Clive M.
Li, Gui-Rong
Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases
title Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases
title_full Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases
title_fullStr Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases
title_full_unstemmed Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases
title_short Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes: Evidence for Dual Regulation by Src and EGFR Kinases
title_sort differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: evidence for dual regulation by src and egfr kinases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217456/
https://www.ncbi.nlm.nih.gov/pubmed/15024039
http://dx.doi.org/10.1085/jgp.200409013
work_keys_str_mv AT duxinling differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases
AT gaozhan differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases
AT lauchupak differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases
AT chiushuiwah differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases
AT tsehungfat differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases
AT baumgartenclivem differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases
AT liguirong differentialeffectsoftyrosinekinaseinhibitorsonvolumesensitivechloridecurrentinhumanatrialmyocytesevidencefordualregulationbysrcandegfrkinases